FAKTOR-OPTIONSSCHEIN - RECORDATI INDUSTRIA CHIMICA E FARMA | Real-time Bid/Ask 06:28:02 23/05/2024 pm IST | ||
| 12.87 EUR / 13.05 EUR | +7.46% |
|
| Current month | -14.95% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 23/24/23 | 13.08 | +8.46% |
| 22/24/22 | 12.06 | +3.17% |
| 21/24/21 | 11.69 | +14.83% |
| 20/24/20 | 10.18 | -5.65% |
| 17/24/17 | 10.79 | +13.82% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 02:09 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | Morgan Stanley |
| WKN | MG2XCW |
| ISIN | DE000MG2XCW5 |
| Date issued | 24/04/2024 |
| Strike | 54.92 € |
| Maturity | Unlimited |
| Parity | 0.48 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.04 € |
|---|---|
| Lowest since issue | 7.2 € |
| Spread | 0.18 € |
| Spread % | 1.34% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
49.16
EUR
Average target price
52.24
EUR
Spread / Average Target
+6.27%
- Stock Market
- Certificates
- Certificat
